Literature DB >> 29759344

Right Precordial T-Wave Inversion in Healthy Endurance Athletes Can Be Explained by Lateral Displacement of the Cardiac Apex.

Maria J Brosnan1, Guido Claessen2, Hein Heidbuchel3, David L Prior4, Andre La Gerche5.   

Abstract

OBJECTIVES: The objective of this study was to test the hypothesis that T-wave inversion in the right precordial leads (TWIV2-3) reflects lateral displacement of the heart such that the surface electrocardiographic (ECG) leads overlie a greater proportion of the right ventricle (RV).
BACKGROUND: TWIV2-3 on ECG is more frequently observed among endurance athletes (EAs) than in the general population, the underlying mechanism for which is unclear.
METHODS: Sixty-eight EAs and 41 nonathletic control subjects underwent ECG and cardiac magnetic resonance imaging (CMRI). In addition to standard measurements of biventricular function and volume, novel measurements of cardiac displacement and orientation were analyzed from horizontal long-axis images. These included RV wall thickness in diastole (RVd), cardiac-to-hemithorax area ratio (CHTx%), percentage of circumferential displacement of the RV apex toward the axilla (%LatD), and the angle of interventricular septum with respect to the thoracic midline (∠septal).
RESULTS: All cardiac volume, RVd, CHTx%, %LatD, and ∠septal values were greater in EAs than in controls. Compared to EAs without TWIV2-3, EAs with TWIV2-3 (n = 26) did not have greater RV wall thickness or cardiac volumes (RVd = 4.9 vs. 4.8 mm, p = 0.695; LVEDV = 231 vs. 229 ml, p = 0.856; RVEDV = 257 vs. 254 mL, p = 0.746), but all measurements of cardiac displacement toward the axilla were greater (%LatD = 45.6% vs. 37.9%, respectively, p < 0.0001; ∠septal = 54.23° vs. 48.63°, respectively, p = 0.001; and CHTx% = 46.3% vs. 41.9%, respectively, p = 0.048).
CONCLUSIONS: In healthy EAs, TWIV2-3 is associated with displacement of the RV toward the left axilla rather than RV dilatation or hypertrophy. TWIV2-3 may be explained by the position of the RV relative to that of the surface ECG leads.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARVC; CMRI; ECG; athlete; cardiac MRI; cardiac displacement; right ventricle

Year:  2015        PMID: 29759344     DOI: 10.1016/j.jacep.2015.03.007

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  5 in total

Review 1.  Abnormal ECG Findings in Athletes: Clinical Evaluation and Considerations.

Authors:  Mark Abela; Sanjay Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-12-21

2.  Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Arrhythmogenic Cardiomyopathy.

Authors:  Manuel De Lazzari; Alessandro Zorzi; Alberto Cipriani; Angela Susana; Giulio Mastella; Alessandro Rizzo; Ilaria Rigato; Barbara Bauce; Benedetta Giorgi; Carmelo Lacognata; Sabino Iliceto; Domenico Corrado; Martina Perazzolo Marra
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

Review 3.  Interpretation of T-wave inversion in physiological and pathological conditions: Current state and future perspectives.

Authors:  Flavio D'Ascenzi; Francesca Anselmi; Paolo Emilio Adami; Antonio Pelliccia
Journal:  Clin Cardiol       Date:  2020-04-07       Impact factor: 2.882

4.  Right heart exercise-training-adaptation and remodelling in endurance athletes.

Authors:  Valeria Conti; Filippo Migliorini; Marco Pilone; María I Barriopedro; Juan José Ramos-Álvarez; Francisco Javer Calderon Montero; Nicola Maffulli
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

5.  Electrocardiographic and Echocardiographic Insights From a Prospective Registry of Asian Elite Athletes.

Authors:  Tee Joo Yeo; Mingchang Wang; Robert Grignani; James McKinney; Lay Pheng Koh; Frankie Hun Yau Tan; Gregory Chung Tsing Chan; Nigel Tay; Siew-Pang Chan; Chi-Hang Lee; David Oxborough; Aneil Malhotra; Sanjay Sharma; Arthur Mark Richards
Journal:  Front Cardiovasc Med       Date:  2022-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.